Trial Profile
Late Phase 2 Double-Blind Study to Assess the Dose-Response of JTZ-951 in Anemic Patients with Chronic Kidney Disease Not Requiring Dialysis <Anemia Correction / Switch / Maintenance Study>
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Enarodustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 18 Jan 2017 Status changed from active, no longer recruiting to completed.
- 18 Jun 2016 New trial record